Trial Profile
Effects of monthly injected ibandronate on bone mineral density and microstructure in patients with primary osteoporosis after teriparatide treatment.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Aug 2020
Price :
$35
*
At a glance
- Drugs Ibandronic acid (Primary)
- Indications Osteoporosis
- Focus Therapeutic Use
- Acronyms MONUMENT
- 31 Jul 2020 Status changed from active, no longer recruiting to completed.
- 25 Apr 2018 Status changed from recruiting to active, no longer recruiting.
- 28 Feb 2017 Status changed from not yet recruiting to recruiting.